FIELD: medicine.
SUBSTANCE: invention relates to a compound, which is 2-amino-3-phenylpropyl(aminocarbonyl)carbamate, or its pharmaceutically acceptable salt, or stereoisomer, which can be used for inhibition of dopamine reuptake. The invention also relates to pharmaceutical compositions for inhibition of dopamine reuptake and treatment of diseases associated with dopamine reuptake, which contain therapeutically effective amount of the specified compound, or its pharmaceutically acceptable salt, or stereoisomer.
EFFECT: obtainment of compounds for dopamine reuptake and treatment of associated diseases.
18 cl, 2 tbl, 31 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AMINOCARBONYLCARBAMATE COMPOUNDS | 2015 |
|
RU2688673C2 |
| COMPOUND CONTAINING OXADIAZOLE AND A PHARMACEUTICAL COMPOSITION CONTAINING IT | 2019 |
|
RU2789456C2 |
| PIPERIDINE COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THEREIN AND ITS APPLICATION | 2009 |
|
RU2514827C2 |
| AMINO ALCOHOL DERIVATIVES | 2005 |
|
RU2399614C2 |
| AZALACTAM COMPOUNDS AS HPK1 INHIBITORS | 2019 |
|
RU2801140C2 |
| HYDROXYETHYLAMINOSULFONEAMIDES, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION RETROVIRAL PROTEASES, METHOD OF TREATMENT OF RETROVIRAL INFECTIONS, METHOD OF TREATMENT OF AIDS | 1993 |
|
RU2173680C2 |
| SUBSTITUTED AMIDE COMPOUNDS | 2010 |
|
RU2609021C2 |
| PHENYLCARBAMATE COMPOUNDS FOR APPLICATION IN EPILEPSY PREVENTION OR TREATMENT | 2012 |
|
RU2632659C2 |
| THERAPEUTIC COMPOUNDS AND COMPOSITIONS | 2019 |
|
RU2817800C2 |
| PIPERAZINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION ON THEIR BASIS | 1996 |
|
RU2126001C1 |
